Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
856,187
-
Shares change
-
+8,889
-
Total reported value, excl. options
-
$151,646,117
-
Value change
-
+$1,691,211
-
Number of buys
-
28
-
Number of sells
-
-37
-
Price
-
$177.39
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2024
123 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q3 2024.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 856,187 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (123,443 shares), Miller Investment Management, LP (99,813 shares), MORGAN STANLEY (72,314 shares), WELLS FARGO & COMPANY/MN (71,762 shares), BANK OF AMERICA CORP /DE/ (46,456 shares), COMMONWEALTH EQUITY SERVICES, LLC (30,781 shares), UBS Group AG (27,058 shares), LPL Financial LLC (26,274 shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (24,590 shares), and Royal Bank of Canada (22,502 shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.